canin
viscer
leishmaniasi
leishmania
chagasi
vitro
microbicid
analysi
macrophag
cell
b
r
c
canin
viscer
leishmaniasi
cvl
parasit
diseas
endem
mani
countri
dog
present
major
natur
reservoir
parasit
leishmania
chagasi
syn
l
infantum
biomark
canin
immun
system
import
techniqu
cours
develop
vaccin
treatment
strategi
cvl
new
methodolog
studi
immun
respons
dog
leishmania
infect
receiv
vaccin
treatment
cvl
would
use
context
use
peripher
blood
mononuclear
cell
pbmc
healthi
dog
evalu
procedur
relat
establish
vitro
condit
monocyt
differenti
macrophag
infect
l
chagasi
ii
purif
procedur
tcell
subset
use
microbead
data
demonstr
day
differenti
macrophag
abl
induc
signific
phagocyt
microbicid
activ
l
chagasi
infect
also
show
increas
frequenc
parasit
higher
parasit
load
although
nag
level
present
similar
level
macrophag
cultur
l
chagasi
infect
progress
decreas
myeloperoxidas
mpo
level
hallmark
day
cultur
high
puriti
level
cell
obtain
magnet
separ
column
conclud
monocyt
differenti
macrophag
day
display
intermedi
frequenc
parasit
parasit
load
h
l
chagasi
infect
furthermor
purif
system
use
canin
tlymphocyt
subset
obtain
day
monocyt
differenti
prove
effici
tcell
purif
vitro
analysi
use
l
chagasiinfect
macrophag
purifi
cell
present
prospect
methodolog
could
incorpor
cvl
vaccin
treatment
studi
aim
analyz
microbicid
potenti
induc
specif
andor
cell
crown
copyright
publish
elsevi
bv
right
reserv
leishmaniasi
endem
countri
tropic
subtrop
region
old
new
world
million
case
viscer
leishmaniasi
vl
desjeux
infect
dog
high
densiti
cutan
parasit
main
domest
reservoir
leishmania
chagasi
syn
leishmania
infantum
contribut
propag
parasit
dean
dean
thu
current
strategi
manag
vl
human
center
detect
elimin
seroposit
dog
alongsid
vector
control
therapi
individu
case
tesh
key
goal
control
canin
viscer
leishmaniasi
cvl
develop
vaccin
high
protect
capabl
interrupt
cycl
parasit
transmiss
rei
et
al
assess
vaccin
safeti
anticvl
efficaci
gener
requir
long
followup
stretch
year
studi
giunchetti
et
al
giunchetti
et
al
roatt
et
al
context
develop
methodolog
strategi
enabl
optim
evalu
dog
immun
system
would
highli
relev
test
could
includ
clinic
trial
vaccin
cvl
time
need
experi
could
reduc
would
like
reduc
cost
experiment
use
dog
model
well
provid
ration
way
select
candid
vaccin
cvl
macrophag
play
import
role
control
leishmania
infect
distinct
experiment
model
well
establish
macrophag
particip
kill
parasit
mechan
depend
reactiv
oxygen
nitrogen
intermedi
howev
mechan
macrophag
kill
leishmania
dog
investig
thoroughli
rodrigu
et
al
immun
respons
leishmania
sp
highli
depend
microbicid
action
macrophag
actual
host
cell
target
protozoan
howev
full
capac
antigen
present
establish
effect
respons
parasit
pinelli
et
al
thu
develop
new
approach
analyz
immun
respons
natur
l
chagasiinfect
dog
dog
immun
cvl
vitro
cocultur
system
macrophag
purifi
tlymphocyt
would
use
howev
far
standard
methodolog
purpos
test
usual
involv
system
peripher
blood
mononuclear
cell
pbmc
without
purifi
tlymphocyt
subset
holzmul
et
al
rodrigu
et
al
rodrigu
et
al
develop
addit
methodolog
evalu
immun
system
veterinari
medicin
especi
experiment
dog
model
requir
advanc
would
contribut
identif
biomark
relat
interact
innat
adapt
immun
respons
dog
context
aim
analyz
immun
respons
use
standard
methodolog
cocultur
system
canin
l
chagasiinfect
macrophag
obtain
purifi
cell
approach
could
contribut
identifi
specif
immun
respons
biomark
develop
resist
suscept
profil
cvl
could
use
vaccin
treatment
strategi
parasit
healthi
mongrel
dog
sex
mean
age
month
born
rais
kennel
center
anim
scienc
feder
univers
ouro
preto
use
experi
establish
vitro
condit
monocyt
differenti
macrophag
infect
l
chagasi
n
ii
purif
procedur
tcell
subset
use
microbead
n
anim
receiv
appropri
health
manag
enter
experi
receiv
antihelmint
treatment
plu
chemit
chemitec
agroveterinari
ltda
bra
vaccin
rabi
tecpar
bra
distemp
adenoviru
type
coronaviru
parainfluenza
parvoviru
leptospira
htlp
vanguard
pfizer
bra
studi
protocol
approv
ethic
committe
use
experiment
anim
universidad
feder
de
ouro
preto
ouro
preto
mg
brazil
studi
use
wildtyp
strain
l
chagasi
isol
infect
dog
governador
valadar
mg
previous
character
hamster
moreira
et
al
strain
grown
cultur
medium
nnnlit
sigma
chemic
co
usa
supplement
fetal
bovin
serum
fb
inactiv
cultilab
bra
plu
penicillin
uml
streptomycin
gml
ph
incub
temperatur
c
parasit
use
vitro
test
remov
cultur
stationari
phase
seventh
passag
blood
sampl
five
healthi
dog
ml
collect
heparin
tube
intend
obtain
pbmc
whole
blood
volum
collect
place
mixtur
ficollhypaqu
sigma
chemic
co
usa
densiti
gml
ficollhypaqu
sigma
chemic
co
usa
densiti
gml
ratio
ficollblood
steril
polystyren
conic
bottom
tube
falcon
tm
corn
usa
sampl
centrifug
g
min
c
ring
mononuclear
cell
collect
ficollhypaqu
interfac
transfer
anoth
tube
ml
falcon
steril
pb
contain
fb
tube
centrifug
two
time
g
min
c
supernat
discard
cell
resuspend
ml
cell
cultur
medium
rpmi
cell
count
neubauer
hemocytomet
chamber
determin
number
monocyt
lymphocyt
per
millilit
count
cell
neubauer
chamber
calcul
percentag
monocyt
plate
monocyteswel
use
plate
thermo
fisher
scientif
inc
nunc
usa
circular
coverslip
mm
glasscyto
bra
cultur
establish
use
rpmi
supplement
fetal
calf
serum
fc
macrophag
colonystimul
factor
mcsf
medium
incub
co
mcsf
obtain
supernat
cultur
immort
cell
h
well
gentli
wash
remov
nonadher
cell
transfer
new
plate
thermo
fisher
scientif
inc
nunc
usa
grown
day
fc
time
purif
lymphocyt
undertaken
determin
time
monocyt
differenti
macrophag
high
phagocyt
microbicid
activ
distinct
condit
analyz
duplic
monocyt
differenti
macrophag
evalu
day
cultur
condit
cell
infect
l
chagasi
promastigot
stationari
phase
use
ratio
parasit
per
macrophag
well
wash
gentli
h
infect
cultur
maintain
assess
microbicid
activ
h
postinfect
rate
parasit
infect
count
number
amastigot
macrophag
thu
total
number
amastigot
divid
total
number
infect
macrophag
order
obtain
averag
number
amastigot
per
macrophag
nag
analysi
serv
indic
cellular
activ
level
vitro
infect
variou
differenti
time
monocyt
macrophag
supernat
macrophag
cultur
day
submit
vitro
infect
l
chagasi
promastigot
h
secret
nag
evalu
variou
time
point
infect
nag
level
evalu
plate
thermo
fisher
scientif
inc
nunc
usa
use
supernat
sampl
duplic
dilut
l
citrat
citric
acid
ph
assay
initi
addit
l
substrat
pnitrophenyl
nacetyldglucosaminid
sigma
chemic
co
usa
dilut
citratephosph
buffer
citric
acid
na
hpo
ph
final
concentr
mm
submit
incub
c
min
reaction
termin
addit
l
glycin
buffer
glycin
nacl
naoh
ph
plate
read
spectrophotomet
nm
content
supernat
calcul
standard
curv
base
express
activ
nag
mpo
evalu
intend
determin
presenc
polymorphonuclear
cell
cultur
day
differenti
addit
control
cultur
puriti
thu
l
supernat
place
duplic
plate
thermo
fisher
scientif
inc
nunc
usa
l
hcl
tetramethylbenzidin
tmb
promega
corpor
usa
h
subsequ
ad
plate
incub
c
min
reaction
termin
addit
l
h
well
enzym
activ
determin
colorimetr
use
plate
reader
biotek
el
ultra
micropl
reader
usa
wavelength
nm
express
optic
densiti
purif
lymphocyt
perform
use
total
healthi
control
dog
peripher
blood
sampl
collect
anim
obtain
pbmc
use
ficollhypaqu
sigma
chemic
co
usa
densiti
gradient
centrifug
section
first
separ
ficollhypaqu
gradient
pbmc
maintain
h
adhes
monocyt
period
nonadher
cell
separ
addit
cultur
day
total
day
cultur
time
lymphocyt
submit
purif
ficollhypaqu
method
lymphocyt
isol
use
magnet
bead
miltenyi
biotec
inc
usa
posit
select
use
fluorescein
isothiocyan
antibodi
abd
serotec
uk
microbead
coat
antifitc
briefli
cell
suspens
prepar
concentr
cell
tube
isol
buffer
contain
pb
ph
bsa
mm
edta
monoclon
antibodi
ad
lml
total
lymphocyt
incub
room
temperatur
rt
min
magnet
microbead
ad
lml
lymphocyt
incub
min
rt
cell
suspens
load
onto
mac
column
miltenyi
biotec
inc
usa
place
magnet
field
mac
separ
magnet
label
cell
retain
column
unlabel
cell
ran
thu
cell
fraction
deplet
cell
remov
column
magnet
field
magnet
retain
cell
elut
posit
select
cell
fraction
wash
magnet
column
ml
isol
buffer
puriti
cell
evalu
flow
cytometri
facscalibur
instrument
becton
dickinson
usa
interfac
appl
workstat
cellquest
softwar
becton
dickinson
usa
use
data
acquisit
analysi
total
event
acquir
prepar
flow
cytometr
analysi
perform
use
canin
whole
blood
leukocyt
select
basi
characterist
forward
fsc
side
ssc
lightscatt
distribut
follow
fsc
ssc
gain
adjust
lymphocyt
select
gate
fsc
versu
ssc
graph
fluoresc
evalu
fitc
spectra
antibodi
dot
plot
represent
marker
set
intern
control
nonspecif
bind
order
encompass
unlabel
cell
marker
use
analyz
data
individu
anim
result
express
percentag
posit
cell
within
select
gate
cell
surfac
marker
present
statist
analysi
perform
use
instrument
support
softwar
graphpad
prism
prism
softwar
usa
data
normal
demonstr
kolmogorovsmirnoff
test
analys
macrophag
cultur
infect
number
amastigot
nag
mpo
perform
anova
employ
repeat
measur
pair
data
consid
statist
signific
p
valu
cultiv
period
chang
observ
cultur
monocyt
adher
cover
slip
differenti
macrophag
day
cultur
began
fig
day
differenti
even
well
wash
larg
number
granulocyt
well
mononuclear
cell
remain
attach
fig
b
contrast
monocyt
differenti
macrophag
fourth
day
cultur
alreadi
demonstr
morpholog
chang
increas
size
cytoplasm
vacuol
irregular
shape
fig
fifth
day
matur
morpholog
chang
remain
increas
cell
size
number
nuclei
giant
cell
cytoplasm
vacuol
fig
monocyt
differenti
macrophag
day
cultur
increas
frequenc
parasit
higher
parasit
load
phagocyt
abil
monocyt
differenti
macrophag
assess
h
l
chagasi
promastigot
use
infect
monocyt
day
differenti
fig
monocyt
analyz
h
l
chagasi
infect
shown
fig
percentag
macrophag
infect
l
chagasi
statist
higher
p
base
length
time
monocyt
differenti
macrophag
thu
monocyt
differenti
day
cultur
show
significantli
higher
percentag
l
chagasi
infect
relat
time
evalu
day
day
day
similarli
higher
parasit
load
observ
base
time
period
monocyt
differenti
macrophag
fig
day
differenti
significantli
enhanc
number
amastigotesmacrophag
compar
time
day
day
day
monocyt
differenti
day
show
statist
p
lower
frequenc
l
chagasiinfect
macrophag
h
relat
h
h
fig
fig
show
increas
frequenc
parasit
h
compar
h
h
h
p
fig
show
lower
frequenc
parasit
occur
h
compar
h
addit
lower
frequenc
parasit
describ
h
h
h
compar
h
observ
reduc
frequenc
l
chagasiinfect
macrophag
h
comparison
h
h
fig
moreov
lower
frequenc
l
chagasiinfect
macrophag
observ
h
h
h
relat
h
fig
h
show
similar
profil
describ
frequenc
l
chagasiinfect
macrophag
base
differ
differenti
time
analysi
nag
evalu
lysosom
hydrolas
level
macrophag
show
signific
differ
p
day
differenti
fig
decreas
nag
level
h
observ
relat
h
differenti
durat
time
point
postinfect
pattern
releas
enzym
cultur
supernat
similar
progress
decreas
level
mpo
monocytemacrophag
cultur
supernat
day
cultur
hallmark
macrophag
differenti
h
leishmania
infect
three
hour
infect
mpo
level
significantli
reduc
monocyt
differenti
day
day
relat
cultur
day
day
relat
day
p
data
suggest
develop
cultur
high
degre
puriti
given
enzym
secret
primarili
granulocyt
contain
azurophil
granul
furthermor
note
given
short
life
pmnc
almost
certainli
apoptot
stage
fifth
day
cultur
fig
high
puriti
level
subpopul
obtain
protocol
describ
studi
methodolog
took
account
larg
amount
circul
granulocyt
peripher
blood
dog
graph
differ
profil
pbmc
purif
shown
fig
f
shown
fig
ficol
gradient
use
demonstr
lower
percentag
monocyt
compar
result
ficol
gradient
fig
fig
show
pbmc
profil
cultur
plate
fifth
day
cultur
substanti
cell
debri
lymphocyt
contrast
fig
lymphocyt
pass
doubl
ficol
level
lymphocyt
higher
percentag
lymphocyt
puriti
use
antibodi
sort
use
magnet
column
demonstr
high
level
fig
procedur
illustr
pbmc
obtain
distinct
strategi
base
ficol
densiti
gradient
ad
use
establish
puriti
percentag
tcell
e
f
ad
display
pbmc
select
basi
characterist
forward
fsc
side
ssc
lightscatt
distribut
differ
fsc
versu
ssc
graph
demonstr
pbmc
pattern
obtain
applic
whole
blood
leukocyt
ficol
gradient
densiti
applic
whole
blood
leukocyt
ficol
gradient
densiti
b
applic
whole
blood
leukocyt
ficol
gradient
densiti
maintain
cultur
day
c
applic
whole
blood
leukocyt
ficol
gradient
densiti
maintain
cultur
day
resubmit
anoth
purif
use
ficol
gradient
densiti
percentag
lymphocyt
puriti
demonstr
select
gate
fsc
versu
ssc
graph
display
puriti
frequenc
cell
marker
e
f
fitc
label
fig
fig
tcell
purif
immun
respons
leishmania
sp
highli
depend
microbicid
action
macrophag
although
host
target
cell
protozoan
full
capac
antigen
present
establish
effect
respons
parasit
pinelli
et
al
methodolog
could
employ
immunogen
studi
test
candid
vaccin
cvl
thu
microbicid
abil
antigenspecif
cell
cocultur
leishmaniainfect
macrophag
could
investig
dog
test
vaccin
treatment
strategi
cvl
result
indic
differenti
macrophag
day
cultur
induc
increas
phagocyt
microbicid
activ
fig
moreov
time
point
possibl
observ
multinucl
giant
cell
vacuol
cytoplasm
result
encourag
macrophag
stage
matur
satisfactori
applic
vitro
experi
use
l
chagasi
infect
furthermor
differenti
peripher
blood
monocyt
macrophag
permit
obtain
cell
less
invas
punctur
periton
compart
zhang
et
al
sampaio
et
al
morpholog
point
view
presenc
multinucl
giant
cell
cell
fusion
cultur
monocyt
differenti
macrophag
report
human
howev
known
varieti
inflammatori
condit
gener
cell
gerberd
yoder
cell
previous
report
canin
macrophag
studi
ho
babiuk
howev
cell
fusion
occur
cultur
week
addit
propos
virtual
pure
cultur
day
cultur
macrophag
maintain
month
vitro
condit
howev
noteworthi
longer
durat
cultur
greater
chanc
contamin
differ
microorgan
therefor
would
help
standard
cultur
experi
could
perform
quickli
context
gotokoshino
et
al
describ
standard
method
use
canin
macrophag
day
differenti
studi
phagocyt
abil
latex
microspher
consensu
period
cell
mainten
cultur
may
rang
day
wardley
et
al
incub
monocyt
use
macrophag
bueno
et
al
attempt
optim
obtain
larger
number
macrophag
deriv
canin
peripher
blood
monocyt
compar
result
cell
cultur
kept
teflon
flask
separ
ficol
gradient
studi
day
cultur
possibl
obtain
canin
macrophag
furthermor
rate
l
chagasiinfect
macrophag
h
infect
respect
result
similar
panaro
et
al
howev
except
result
h
intern
l
chagasi
observ
current
studi
fig
infect
rate
result
obtain
h
infect
bueno
et
al
accord
present
studi
found
gradual
reduct
frequenc
parasit
parasit
load
number
amastigotesm
base
time
l
chagasi
infect
especi
monocyt
longer
period
cell
differenti
day
thu
becam
evid
monocyt
differenti
day
macrophag
show
greater
microbicid
abil
probabl
due
stage
matur
indirect
dosag
lysosom
enzym
nag
show
cell
activ
least
h
l
chagasi
infect
sinc
show
constant
level
enzym
throughout
period
analysi
h
fig
howev
except
macrophag
day
differenti
enzym
level
significantli
reduc
h
postinfect
p
enzym
level
similar
time
result
consist
obtain
kausalya
et
al
found
releas
pattern
nag
periton
macrophag
balbc
similar
peak
releas
day
post
l
donovani
infect
moreov
studi
chakraborti
da
infect
l
donovani
periton
macrophag
hamster
result
drastic
reduct
level
nag
h
follow
infect
furthermor
analysi
nag
level
reproduc
increas
dead
parasit
cell
cultur
medium
indic
inhibit
enzym
level
relat
characterist
live
parasit
chakraborti
da
higher
microbicid
activ
close
relat
number
activ
macrophag
henc
high
level
secret
lysosom
hydrolas
akporiay
et
al
moreov
meagher
et
al
describ
apoptot
neutrophil
studi
use
addit
macrophag
suffici
induc
high
level
nag
compar
zymosan
data
indic
apoptot
neutrophil
cultur
day
may
interfer
secret
lysosom
enzym
due
phagocyt
activ
macrophag
fact
present
studi
morpholog
characterist
describ
differ
macrophag
differenti
time
indic
presenc
granulocyt
low
addit
result
relat
morpholog
analysi
phagocytosi
microbicid
activ
enzymat
nag
mpo
activ
previou
report
literatur
confirm
ideal
cultur
condit
canin
monocyt
differenti
macrophag
obtain
day
vitro
monocyt
incub
canin
immun
system
sever
peculiar
especi
relat
number
circul
granulocyt
blood
stream
neutrophil
present
high
express
molecul
william
featur
interfer
purif
cell
high
puriti
use
typic
method
separ
thu
use
peripher
blood
sampl
perform
tcell
separ
increas
contamin
canin
neutrophil
avoid
best
altern
establish
purif
system
carri
fifth
day
monocyt
differenti
lower
level
granulocyt
present
strategi
allow
increas
perform
puriti
level
use
magnet
column
methodolog
fig
data
present
describ
ideal
condit
vitro
differenti
monocyt
deriv
canin
peripher
blood
macrophag
base
data
present
conclud
monocyt
differenti
macrophag
cours
day
display
intermedi
frequenc
parasit
parasit
load
h
l
chagasi
infect
time
inclus
purifi
andor
cell
infect
macrophag
cultur
would
use
analyz
impact
modul
vitro
parasit
furthermor
purif
system
use
canin
tlymphocyt
subset
day
monocyt
differenti
prove
effici
obtain
cultur
permit
high
tcell
puriti
thu
use
cocultur
system
employ
canin
monocyt
differenti
macrophag
purifi
andor
cell
may
contribut
analysi
adapt
immun
respons
dog
methodolog
could
incorpor
vaccin
treatment
studi
cvl
aim
analyz
microbicid
potenti
induc
specif
andor
cell
